BioCardia Inc. (BCDAW)
NASDAQ: BCDAW
· Real-Time Price · USD
0.01
0.00 (58.73%)
At close: Aug 02, 2024, 10:00 PM
BioCardia Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 58K | 71K | 428K | 468K | 477K | 570K | 425K | 1.36M | 1.35M | 1.32M | 1.93M | 1.03M | 1.01M | 982K | 195K | 153K |
Cost of Revenue | 212K | 317K | 421K | 416K | 411K | 12.21M | 12.21M | 14.6M | 14.59M | 15.32M | 17.45M | 17.32M | 19.07M | 8.77M | 9M | 8.86M |
Gross Profit | -154K | -246K | 7K | 52K | 66K | -11.64M | -11.78M | -13.25M | -13.24M | -13.99M | -15.52M | -16.29M | -18.06M | -7.79M | -8.81M | -8.71M |
Operating Income | -8M | -7.76M | -8.58M | -10.38M | -11.62M | -12.55M | -13.04M | -12.08M | -11.9M | -12.34M | -11.99M | -12.98M | -12.63M | -12.67M | -13.81M | -13.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 3K | 5K | 9K | 10K | 9K | 9K |
Pretax Income | -7.95M | -7.72M | -8.56M | -10.34M | -11.57M | -12.53M | -13.01M | -12.08M | -11.91M | -12.34M | -11.99M | -12.98M | -12.62M | -12.15M | -13.29M | -13.38M |
Net Income | -7.95M | -7.72M | -8.56M | -10.34M | -11.56M | -12.53M | -13.01M | -12.08M | -11.91M | -12.34M | -11.99M | -12.98M | -12.63M | -12.15M | -13.29M | -13.38M |
Selling & General & Admin | 3.57M | 3.52M | 3.77M | 4.1M | 4.31M | 4.38M | 4.42M | 4.41M | 4.42M | 4.92M | 5.08M | 5.11M | 5.09M | 4.88M | 5M | 5.18M |
Research & Development | 4.39M | 4.11M | 5.05M | 6.56M | 7.71M | 8.77M | 9.04M | 9.03M | 8.83M | 8.75M | 8.85M | 8.9M | 8.56M | 8.77M | 9M | 8.86M |
Other Expenses | 8K | 20K | 44K | 72K | 73K | 51K | 30K | 1K | -6K | 3K | 2K | 5K | 2K | 2K | -1K | -4K |
Operating Expenses | 7.95M | 7.62M | 8.82M | 10.67M | 12.02M | 13.15M | 13.46M | 13.44M | 13.25M | 13.67M | 13.93M | 14.01M | 13.64M | 13.65M | 14M | 14.04M |
Interest Expense | n/a | 9K | 9K | 9K | 9K | 10K | 10K | 11K | 11K | 2K | 4K | 5K | 9K | 9K | 8K | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.06M | 7.83M | 9.03M | 10.88M | 12.12M | 13.15M | 13.46M | 13.44M | 13.25M | 13.67M | 13.93M | 14.01M | 13.64M | 13.65M | 14M | 14.04M |
Income Tax Expense | 62.72K | 68.72K | 71.72K | -29.36K | -101.08K | -97.08K | -103.08K | -1K | 6K | 2K | 1K | -4K | -9K | -524K | -519K | -518K |
Shares Outstanding (Basic) | 2.74M | 2.83M | 1.88M | 1.68M | 1.5M | 1.44M | 1.36M | 1.35M | 1.22M | 1.19M | 1.18M | 1.14M | 1.14M | 1.14M | 1.14M | 1.1M |
Shares Outstanding (Diluted) | 1.88M | 2.83M | 1.88M | 1.68M | 1.5M | 1.44M | 1.36M | 1.35M | 1.22M | 1.19M | 1.18M | 1.14M | 1.14M | 1.14M | 1.14M | 1.1M |
EPS (Basic) | -3.68 | -4.22 | -5.4 | -7.04 | -8.29 | -9.4 | -10.18 | -9.78 | -10.1 | -10.66 | -10.47 | -11.42 | -11.19 | -11.51 | -13.7 | -17.58 |
EPS (Diluted) | -4.06 | -4.22 | -5.4 | -7.04 | -8.29 | -9.4 | -10.18 | -9.78 | -10.1 | -10.66 | -10.47 | -11.42 | -11.19 | -11.51 | -13.7 | -17.58 |
EBITDA | -7.85M | -7.61M | -8.44M | -10.24M | -11.56M | -12.49M | -12.95M | -12M | -11.82M | -12.26M | -11.92M | -12.92M | -12.56M | -12.19M | -13.33M | -13.41M |
EBIT | -8M | -7.76M | -8.61M | -10.41M | -11.64M | -12.58M | -13.04M | -12.08M | -11.9M | -12.34M | -11.98M | -12.98M | -12.62M | -12.16M | -13.3M | -13.38M |
Depreciation & Amortization | 154K | 244K | 332K | 416K | 411K | 403K | 403K | 391K | 377K | 457K | 512K | 578K | 640K | 479K | 336K | 195K |